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Abstract
The aim of this study was to assess the presence of alcohol, illicit drugs and medicinal drugs among Spanish drivers involved
in fatal road accidents between 1991 and 2000. Samples were obtained for 5745 drivers killed in road accidents from January
1991 to December 2000. Of the samples, 91.7% represented males and 8.3% females; 40.7% were under 30 years of age, 31.9%
were under 31–50 years of age, 19.5% were over 51 years of age, and for 7.9% the age was unknown. Between 1991 and 2000,
some type of psychoactive substance was detected among 50.1% of those drivers killed in road accidents, this being mainly
alcohol (43.8%) and, less frequently, illicit drugs (8.8%) and medicinal drugs (4.7%). In all the cases, in which alcohol was
detected, combined use with other substances accounted for only 12.5%, whilst in the case of illicit and medicinal drugs, figures
representing combined use with other substances were 75.6% for the former and 65.8% for the latter. For one in every three cases
(32.0%), a blood alcohol level over 0.8 g/l was recorded; cocaine (5.2%), opiates (3.2%) and cannabis (2.2%) were the three
illicit drugs most frequently detected. Among medicinal drugs, were benzodiazepines (3.4%), anti-depressant drugs (0.6%) and
analgesics (0.4%). The results show the frequent presence of psychoactive substances, particularly alcohol, among Spanish
motor vehicle users involved in fatal road accidents. It should be pointed out that illicit and medicinal drugs in combination with
other substances were a common feature. # 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Research has shown that alcohol impairs driving skills
and increases crash risk [1]. Within the European Union,
average yearly road traffic accidents between 1991 and 1998
involved 10,000 (21.3%), out of the 47,000 fatal accidents,
related to alcohol [2]. In the last years, research has shown
that illicit drugs and certain medicinal drugs also impair
driving skills and can increase crash risk [3,4]. Therefore, as
drink-driving is decreasing in some countries, the role
played by illicit and medicinal drugs has become the object
of increasing interest [5,6].
In a recent review [7,8], it was shown that the presence of
alcohol and drugs among injured drivers (36 and 19%,
respectively) and drivers killed on the roads (31.7 and
16.3%, respectively) was a common feature. In the study
conducted by Gier [9] for the Pompidou Group, Council of
Europe, and based on 13 European countries, certain inter-
esting findings were obtained. Among the general driver
population, the prevalence of illicit drug use was in the range
of 1–5%, while that of medicinal drugs represented 5–15%.
Among those drivers suspected of driving under the influ-
ence of drugs, a high prevalence of medicinal drugs was
reported (14–74%), while the prevalence of illicit drugs was
lower (9–57% for cannabis, 8–42% for opiates and 1–20%
for amphetamines). Regarding collision-involved drivers,
the prevalence of illicit drugs ranged from 10 to 25% (in
fatal road accidents) and, in the case of medicinal drugs,
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from 6 to 21%. The author [9] also pointed out the diffi-
culties encountered when comparing the different studies.
The evidence available in Spain indicates that alcohol
consumption and use of other psychoactive substances are
frequent among motor vehicle users, and that driving under
the influence of these substances is equally customary
[10,11]. Only in the last few years has information begun
to be available about the involvement of psychoactive sub-
stances in the incidence of traffic accidents [12–14].
Current legislation in Spain states that one may not drive
under the influence of psychoactive substances (illicit drugs
and medicinal drugs) that may alter the physical or mental
state in which one is fit to drive without danger (Royal
Decree 13/1992). Likewise, maximum permissible blood
alcohol levels among motor vehicle users have been estab-
lished for several decades. On 7 May 1999, Royal Decree
2282/1998 became effective, establishing blood alcohol
concentrations and formalising tests on motor vehicle users,
as well as modifying the legislation which had been in effect
until that time under the General Driving Regulations (Royal
Decree 13/1992). In accordance with the new legislation,
motor vehicle users are not allowed to drive if their blood
alcohol concentration is greater than 0.5 g/l (or 0.25 mg/l in
exhaled air). These limits are 0.3 g/l (0.15 mg/l in exhaled
air) for users of vehicles intended for transporting goods,
passengers/school children, hazardous goods, special trans-
portation, etc. as well as for any operator in the first 2 years
after obtaining a driver’s licence or permit [12,13].
In this study, we analyse the data from the National
Toxicological Centre regarding the presence of substances
in motor vehicle drivers killed in road accidents. The aim is
to determine the role that alcohol, illicit drugs and medicinal
drugs play in the incidence of traffic accidents, as well as to
analyse their evolution over the last 10 years (1991–2000). A
preliminary version was presented at the ICADTS Confer-
ence in Stockholm [14].
2. Material and methods
Samples from 5745 drivers killed in road accident, from
January 1991 to December 2000, were obtained. Sample
distribution according to year was as follows: 1991, 259;
1992, 250; 1993, 199; 1994, 244; 1995, 279; 1996, 383;
1997, 487; 1998, 1090; 1999, 1191; 2000, 1363. A total of
91.7% (n ¼ 5266) of the samples were from males and 8.3%
(n ¼ 479) from females. As regards age range, 10.0% (n ¼
575) were under 20 years of age; 30.7% (n ¼ 1763) were
aged 21–30 years; 19.3% (n ¼ 1107) were aged 31–40 years;
12.6% (n ¼ 726) were aged 41–50 years; 8.9% (n ¼ 511)
were aged 51–60 years; 10.6% (n ¼ 611) were over 60 years
of age; in the rest of the cases 7.9% (n ¼ 452), the age was
unknown.
The cases correspond to samples referred to the National
Toxicological Centre (Instituto Nacional de Toxicologı´a) by
forensic doctors or as instructed by the judge.
Blood samples were analysed for alcohol (ethanol) by
Head-Space Gas chromatography) [12–14]. All samples
were also screened for the presence of drugs other than
alcohol (medicines and illicit drugs) by immunological or
chromatographic methods when appropriate. The cut-off
levels of the first screening were: opiates 300 ng/ml; cocaine
metabolite 150 ng/ml; cannabinoids 20 ng/ml; ampheta-
mines 300 ng/ml; benzodiazepines 200 ng/ml.
Positive results after screening were confirmed by means of
gas chromatography–mass spectrometry (GC–MS), and con-
centrations of psychoactive drugs or metabolites were deter-
mined [12–14]. In the case of opiates, amphetamines and
cocaine, the cut-off levels for the GC–MS confirmation test
were in the selected ion monitoring mode (SIM) 50 ng/ml,
and 10 ng/ml in the case of cannabis. Positive results were
confirmed by GC–nitrogen–phosphorus flame-ionisation
detection (GC–NPFID) for benzodiazepines (cut-off 0.1 mg/
ml) and for the analgesic drug dipyrone (cut-off 1 mg/ml).
Substances other than alcohol were classified in two
groups: illicit drugs and medicines. In the first group,
categorisation into the following groups was established:
opiates, cocaine, cannabis, amphetamines, synthetic drugs
(ecstasy) and hallucinogenic drugs. In the second group,
different sub-groups were established, in accordance with
the Anatomical Therapeutic Chemical classification system.
The analytical results were expressed as follows: (i) no
substance detected, or (ii) some type of substance detected.
Once a substance had been detected, samples were classified
in the following groups: (i) alcohol alone, (ii) alcohol plus
medicinal drugs, (iii) alcohol plus illicit drugs, (iv) alcohol
plus medicinal drugs plus illicit drugs, (vi) illicit drugs alone,
(vii) medicinal drugs alone, (viii) illicit drugs plus medicinal
drugs.
Calculation was made of the percentage referring to the
cases in which alcohol, medicinal drugs and illicit drugs, as
well as their possible combinations, were found. For alcohol,
cases in which blood alcohol concentration was equal to, or
over 0.8 g/l, and equal to, or over 0.5 g/l for 1999 and 2000,
were shown.
Between 1991 and 2000, 59,071 people were killed in
road accidents in Spain (Fig. 1). The smallest number of
deaths occurred in 1996 (5483) and the largest number in
1991 (6797). Within that period of time, the Spanish popula-
tion changed from 38.9 million inhabitants in 1991 to 39.5
million inhabitants in 2000. As shown in Fig. 1, the number
of drivers in those years increased gradually from 16.9
million in 1991 to 21.4 million in 2000. This was due to
the gradual increase in the number of women obtaining a
driving licence. Consequently, in 1991, 31 out of every 100
drivers were women, whereas, in 2000, the number was 35
out of every 100.
Data analysis was conducted in the Data Processing
Center at Valladolid University. Statistic analysis was by
means of SAS software version 6.12 (SAS Institute SAS).
An analysis of variance test (ANOVA) was employed. P-
values <0.05 were considered to be significant differences.
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3. Results
A total of 5745 blood samples were taken from the 59,071
drivers killed in road accidents between 1991 and 2000. That
is to say that the presence of substances was analysed in only
9.7% of fatal road accident cases. However, this percentage
increased gradually from 3.8% in 1991 to 23.8% in 2000
(Fig. 1).
As demonstrated in Fig. 2, in 50.1% of cases some psy-
choactive substance, mainly alcohol (43.8%), was detected
and, to a lesser extent, illegal drugs (8.8%) and medicines
(4.7%). These three percentages exceeded 100%, since
several of these substances could be found in just one case.
The mean of substances detected in positive cases is 1:19
0:52 (mean S:D:), varying according to the presence of
alcohol, illicit drugs or medicinal drugs (F ¼ 720:62,
P < 0:0001).
3.1. Alcohol
In alcohol-detected cases (n ¼ 2517, 43.8%, Fig. 2),
alcohol alone was present in the majority (n ¼ 2195,
38.2%, Fig. 2; 87.5% of all alcohol-detected cases). Alcohol
combined with drugs was much less common (n ¼ 230,
Fig. 1. Evolution of the number of drivers, of road accident victims, and analyses of fatalities in Spain between 1991 and 2000.
Fig. 2. Presence of substances among drivers involved in fatal road accidents, Spain, 1991–2000.
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4.0%), followed by alcohol and medicinal drugs (n ¼ 68,
1.2%), and alcohol, drugs and medicinal drugs (n ¼ 24,
0.4%). The mean of substances detected in those cases in
which alcohol was present was 1:13 0:37 (mean S:D:).
Between 1991 and 2000, in 32.0% (n ¼ 1836) of all
cases, blood concentration was higher than 0.8 g/l (the legal
limit until 6 May 1999); in other words, in nearly one in
every three cases the concentration level was higher than that
permitted by law. In 1999 and 2000, in 29.8% (n ¼ 355) and
32.6% (n ¼ 444) of the cases, respectively, blood concen-
tration was found to be over 0.5 g/l (the legal limit estab-
lished from 7 May 1999).
3.2. Illegal drugs
Between 1991 and 2000, at least one illegal drug was
detected in 8.8% (n ¼ 504) of the people killed in road
accidents. In most cases, illegal drugs and substances other
than alcohol were detected: in 4.0% (n ¼ 230) together with
alcohol, in 1.2% (n ¼ 67) with medicinal drugs, and in 0.4%
(n ¼ 24) with alcohol and medicinal drugs (Fig. 2). That is to
say, that in 63.7% (321 out of 504) of all the cases in which
an illegal drug was detected, alcohol and/or medicinal drugs
were also present. Moreover, with regard to the cases in
which only illegal drugs were found (n ¼ 183; 3.2%), at
least two illicit drugs were detected in combined use in 60 of
the 183 cases. In other words, two or more substances were
actually present in 75.6% (381 out of 504) of the cases in
which illicit drugs were found. The mean of substances
detected in cases in which one illegal drug appeared was
1:86 0:62, and this was higher than when alcohol was
detected (F ¼ 1236:15, P < 0:001) or medicinal drugs
(F ¼ 6:21, P < 0:01).
An analysis of the drugs detected shows that cocaine was
the most common (n ¼ 300, 5.2%) followed by opiates
(n ¼ 186, 3.2%), cannabis (n ¼ 127, 2.2%), amphetamines
(n ¼ 67, 1.2%) and designer drugs (n ¼ 33, 0.6%).
We analysed in greater detail the cases in which cocaine
was detected (n ¼ 300), as it happened to be the most
common drug found. As shown in Fig. 3, in 82% of the
cases, cocaine was present with some other substance. In
more than half of the cases cocaine was detected together
with alcohol (54.3%). Besides, cocaine was commonly
found with other illicit drugs (39.7%). The presence of
cocaine with medicinal drugs was less frequent (17.3%).
Their possible combinations appear in Fig. 3.
3.3. Medicines
Between 1991 and 2000, medicines were detected in
4.7% (n ¼ 269) of the cases. As for the presence of other
substances in combination with medicines, in 59.1% (159
out of 269) of the cases in which medicines were found,
alcohol and/or illegal drugs were present (Fig. 2). In 18 out
of the 110 cases in which only medicines were detected, two
or more medicines were present. That is to say, that in reality
Fig. 3. Presence of cocaine among Spanish drivers involved in fatal road accidents, Spain, 1991–2000.
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two or more substances were detected in 65.8% (177 from
269) of the cases in which some medicine was found. The
mean of substances detected in cases involving some med-
icinal drug was 1:74 0:60, greater than when alcohol was
detected (F ¼ 564:96, P < 0:001) and lower when illicit
drugs were found (F ¼ 6:21, P < 0:01), as was mentioned
above.
Benzodiazepines represented the most commonly
detected group of medicines (n ¼ 196, 3.4%), followed in
decreasing order by anti-depressants (n ¼ 33, 0.6%), analge-
sics (n ¼ 26, 0.4%), anti-epileptic drugs (n ¼ 18, 0.3%),
barbiturates (n ¼ 15, 0.3%), H-1 anti-histamines (n ¼ 15,
0.3%), vasodilators (n ¼ 9, 0.15%), calcium antagonists
(n ¼ 8, 0.14%), anti-hemetic drugs (n ¼ 1, 0.01%) and
anti-psychotic drugs (n ¼ 1, 0.01%).
As in the case of illegal drugs, we have analysed more
carefully the cases in which benzodiazepines were detected
(n ¼ 196), as this drug was the one most commonly traced.
As may be observed in Fig. 4, in 72.4% of cases, benzo-
diazepines were detected together with some other sub-
stance, mainly illegal drugs (41.3%) and alcohol (33.7%),
and less frequently, with other medicines (14.8%).
4. Discussion
This study shows that the presence of substances (50.1%)
in Spanish drivers killed in traffic accidents and from whom
blood samples were taken and analysed for alcohol and other
drugs is by no means negligible. Although alcohol is the
most commonly detected substance, the presence of illicit
and medicinal drugs cannot be ignored either. Regarding
alcohol, it should be pointed out that it was frequently
detected (43.8%), and that it was often over 0.8 g/l
(32.0%). In cases in which illegal drugs (8.8%) and med-
icinal drugs (4.7%) were detected, it is noteworthy that in
most cases these were found alongside other substances
(75.6 and 65.8%, respectively), with cocaine (5.2%) and
benzodiazepines (3.4%) being the substances most com-
monly traced in relation to illicit and medicinal drugs.
In a previous study [12,13], conducted on 259 Spanish
drivers killed in traffic accidents between 1994 and 1996
(randomly selected and for no legal purpose), at least one
type of substance was detected in 60.0% of the cases,
alcohol in 50.5% (0.8 g/l in 35.4%), illicit drugs in
10.2% and medicinal drugs in 9.1%. These figures are
higher than those observed in the present study between
1991 and 2000.
Our findings show a high level of psychoactive sub-
stances in road accident victims. Nevertheless, we believe
that these figures must be viewed with caution, since the
number of drivers killed in whom substances were detected
is very low (9.7% of road deaths). How can this be
explained? Up to 1996 (B.O.E. 23/XII/1996, pp. 38203–
38221) testing for alcohol (or other drugs) was not a formal
requirement in Spain. As a result, the number of road
Fig. 4. Presence of benzodiazepines among Spanish drivers involved in fatal road accidents, Spain, 1991–2000.
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accident victims analysed for alcohol (or other drugs) was
very low. In fact, this situation was referred to colloquially
as the ‘widow syndrome’: that is to say, no interest was
shown as to whether the victim was under the influence of
alcohol or not; it was preferred that the insurance compa-
nies paid the families of the victims and the incidents were
forgotten. Consequently, there was always the suspicion
that that tests for blood alcohol (and other drugs) concen-
tration were carried out only in cases in which the victim
showed clear signs of being under the effect of alcohol.
Since 1996, the year in which the law came out, testing for
alcohol has increased significantly (3.8% in 1991 as against
23.8% in 2000), which enhances the trustworthiness of
these findings.
Concerning alcohol, although comparison with data from
other countries should be carefully conducted, the figures
observed in our study were among the highest. In the UK
[15], data accumulated from 1990 to 1994 revealed that in
45.5% of deaths alcohol was detected, and that this exceeded
0.8 g/l in 20.25% of the victims. Recent data from 1997 [16]
reveals that alcohol over 0.8 g/l was detected in 23% of all
victims. Alcohol has been frequently detected in Italy
(49.0%) [17], in France (45:7% > 0:7 g/l) [18] and in Bel-
gium (28% over 0.49 g/l) [19], whilst figures for the Nordic
countries (Sweden: 27% [20] and 20.3% [21], Norway:
28.3% [22]) are considerably lower, perhaps as a result of
the fact that in these countries there exists a very strict policy
with regard to drinking and driving. High figures have also
been recorded for Canada (48%) [23] and some areas of the
USA (46%) [24–27], whereas in Australia figures are lower
(36%) [28]. Decreasing trends for drinking and driving have
been observed in some industrialised countries like the USA
[27].
The presence of illicit drugs (8.8%) and medicinal drugs
(4.7%; 11.9% if we consider the presence of both illicit and
medicinal drugs), is lower than that mentioned in previous
reviews [7–9] analysing published studies on road accident
victims. Here figures of 16.3% [7,8] have been quoted when
considering a combination of illicit and medicinal drugs, 10–
25% for illicit drugs, and 6–21% in the case of medicinal
drugs [9]. Although the presence of illicit and medicinal
drugs is much less common than that of alcohol, their
importance should not be underestimated [5,6].
As regards the different kinds of illegal drugs encoun-
tered, in studies carried out in various countries [7,8], the
most commonly found drugs have been cannabis (7.6%),
followed by opiates (3.1%), amphetamines (1.8%) and
cocaine (0.5%). The situation among Spanish drivers killed
in road accidents is completely different: cocaine is the most
frequently detected drug (5.2%), 10.5 times more common
than the mean detected in other studies [7,8], whilst cannabis
was found 3.45 times less frequently (2.2%). As regards
opiates (3.2%) and amphetamines (1.2%; 1.8% if they are
considered alongside designer drugs), frequencies are simi-
lar. We can find no explanation for this greater frequency of
cocaine with respect to cannabis. Although consumption
frequency of the different drugs may vary between countries,
drug-taking patterns are not so different among Spaniards
than among other European Union citizens for these changes
to be accounted for. Cannabis is the most frequently used
substance in the European Union [29].
Benzodiazepines were the most commonly detected med-
icinal drugs (3.4%), albeit with notably less frequency, and
this—despite the fact that the use of benzodiazepines is
particularly common in our country in relation to other
industrialised countries [30]—corresponds with previous
studies (8.5%) [7,8].
An important point is that in most cases involving
detection of illicit drugs (75.6%) and medicinal drugs
(65.8%), at least one other substance was found alongside
them; however, alcohol was detected together with another
substance in only 12.5% of cases. This accounts for the
high average of substances detected in cases in which some
type of illegal drug (1.86) and medicinal drug (1.74) was
found in relation to alcohol (1.13). The prevalence of
multiple substances (alcohol, illicit drugs, medicinal drugs)
used in combination is frequently reported in most of the
studies [7–9,21,23,24]. The combination of various sub-
stances may bring about an increased risk of involvement in
road accidents [5,6].
Drive, crash and injury characteristics among alcohol
and/or drug positive cases in road traffic victims has been
analysed in previous studies [21,22]. Drivers who tested
positive for alcohol and/or drugs were more likely to be
involved in single vehicle crash than those who tested
negative. In the present study, information regarding crash
characteristics was not available. We assume that the present
results represent an unspecified combination of single and
multiple vehicle accidents.
The figures observed in this study between 1991 and 2000
reveal that substances are regularly found in victims of road
accidents in Spain. Several recent reports have made a
detailed analysis of possible intervention and recommenda-
tions both in the area of drinking and driving [6,31–33] and
in that of drugs (illicit and/or medicinal) and driving
[5,6,34,35]. Drink-driving and drugs-driving have to be
tackled in an integrated and multidisciplinary way, with
the inclusion of at least stricter enforcement, tougher punish-
ment, rehabilitation schemes, and continuous public educa-
tion and publicity.
In our country, drinking alcohol forms part of many
people’s daily and social life, and great tolerance and
permissiveness exist with regard to alcohol, thereby making
intervention in this area rather difficult. However, a great
effort is being made with regard to preventive policies,
including, as mentioned earlier, the reduction of the legal
limit.
The present study shows how widespread alcohol con-
sumption is and reveals the high concentration level of this
substance in the blood of fatally injured drivers. Although
the presence of illicit and medicinal drugs is less frequent,
they should, nonetheless, not be dismissed as unimportant.
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Cocaine and benzodiazepines are, respectively, the most
frequent illicit and medicinal drugs detected. As reported
previously [12], alcohol is the main problem in traffic
fatalities in Spain, thereby making it necessary to intensify
efforts and to set up specific programs to reduce drinking and
driving, while also clarifying the role of drugs other than
alcohol in traffic accidents.
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